CANCER PROGRESSION AND P53

被引:155
作者
CARSON, DA [1 ]
LOIS, A [1 ]
机构
[1] UNIV CALIF SAN DIEGO,DEPT MED,LA JOLLA,CA 92093
来源
LANCET | 1995年 / 346卷 / 8981期
关键词
D O I
10.1016/S0140-6736(95)91693-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In a complex organism, somatic cells are under intermittent selection pressure for the emergence of mutants that can survive environmental insults and that can grow autonomously despite adverse conditions. Repeated rounds of mutation, selection, and proliferation may lead to cancer. The organism prevents malignant transformation by assuring accurate DNA repair before cell division, by forcing the death of cells with excessive DNA damage, and by placing limits on the replicative lifespans of most somatic cells. The p53 gene is a ''guardian of the genome''-it regulates multiple components of the DNA damage control response and promotes cellular senescence. Disabling mutations and deletions of p53 occur in 50% of human tumours, p53-deficient cancers are often unstable, aggressive, and resistant to therapy.
引用
收藏
页码:1009 / 1011
页数:3
相关论文
共 23 条
  • [1] BOND JA, 1994, ONCOGENE, V9, P1885
  • [2] CANNON CE, 1995, GENE DEV, V9, P600
  • [3] APOPTOSIS AND DISEASE
    CARSON, DA
    RIBEIRO, JM
    [J]. LANCET, 1993, 341 (8855) : 1251 - 1254
  • [4] TELOMERE SHORTENING ASSOCIATED WITH CHROMOSOME INSTABILITY IS ARRESTED IN IMMORTAL CELLS WHICH EXPRESS TELOMERASE ACTIVITY
    COUNTER, CM
    AVILION, AA
    LEFEUVRE, CE
    STEWART, NG
    GREIDER, CW
    HARLEY, CB
    BACCHETTI, S
    [J]. EMBO JOURNAL, 1992, 11 (05) : 1921 - 1929
  • [5] A P53-DEPENDENT MOUSE SPINDLE CHECKPOINT
    CROSS, SM
    SANCHEZ, CA
    MORGAN, CA
    SCHIMKE, MK
    RAMEL, S
    IDZERDA, RL
    RASKIND, WH
    REID, BJ
    [J]. SCIENCE, 1995, 267 (5202) : 1353 - 1356
  • [6] MICE DEFICIENT FOR P53 ARE DEVELOPMENTALLY NORMAL BUT SUSCEPTIBLE TO SPONTANEOUS TUMORS
    DONEHOWER, LA
    HARVEY, M
    SLAGLE, BL
    MCARTHUR, MJ
    MONTGOMERY, CA
    BUTEL, JS
    BRADLEY, A
    [J]. NATURE, 1992, 356 (6366) : 215 - 221
  • [7] APOPTOSIS IN CANCER-THERAPY - CROSSING THE THRESHOLD
    FISHER, DE
    [J]. CELL, 1994, 78 (04) : 539 - 542
  • [8] FREBOURG T, 1995, AM J HUM GENET, V56, P608
  • [9] DOWN-REGULATION OF WILD-TYPE P53 ACTIVITY INTERFERES WITH APOPTOSIS OF IL-3-DEPENDENT HEMATOPOIETIC-CELLS FOLLOWING IL-3 WITHDRAWAL
    GOTTLIEB, E
    HAFFNER, R
    VONRUDEN, T
    WAGNER, EF
    OREN, M
    [J]. EMBO JOURNAL, 1994, 13 (06) : 1368 - 1374
  • [10] HARVEY M, 1993, ONCOGENE, V8, P2457